Jefferies lifted its price target on ARIAD Pharmaceuticals (NASDAQ: ARIA) from $2.50 to $4 following an update from ASH, but ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE